Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Dalmazi, Giulia, Giuliani, Cesidio, Napolitano, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308315/
https://www.ncbi.nlm.nih.gov/pubmed/30622514
http://dx.doi.org/10.3389/fendo.2018.00777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308315/
https://www.ncbi.nlm.nih.gov/pubmed/30622514
http://dx.doi.org/10.3389/fendo.2018.00777

Ejemplares similares